Vertaling van "national and international " (Nederlands → Frans) :

TERMINOLOGIE

congenitale myopathie met interne nucleï en atypische kernen
myopathie congénitale avec noyaux centrés et cores atypiques

overige stoornissen van interne pancreassecretie
Autres anomalies de la sécrétion pancréatique interne

overige gespecificeerde stoornissen van interne pancreassecretie
Autres anomalies précisées de la sécrétion pancréatique interne

stoornis van interne pancreassecretie
Anomalie de la régulation de la sécrétion pancréatique interne

overige stoornissen van glucoseregulatie en interne pancreassecretie
Autres anomalies de la régulation du glucose et de la sécrétion pancréatique interne

intern osteosynthesemateriaal
système de fixation interne orthopédique

elektrode van interne cardioverter-defibrillator voor kind
électrode de défibrillateur interne pédiatrique

interne rotatiecontractuur van heup
contracture d'une hanche en rotation interne

afdeling interne geneeskunde
service de médecine

interne oftalmoplegie (compleet)(totaal) | paresevan accommodatie | spasmevan accommodatie
Ophtalmoplégie interne (complète) (totale) Parésie | Spasme | de l'accommodation

IN-CONTEXT TRANSLATIONS

Allied and Complementary Medicine Koninklijk Besluit Association des Chiropracticiens Belges Belgian School of Osteopathy (Wet) Beroepen in de Individuele Gezondheidszorg Bristish Medical Association Belgisch Staatsblad Complementary and Alternative Medicine Collège Belge d’Ostéopathie Council of Chiropractic Education Comité Européen de Normalisation/ European committee for Standardization Cumulative Index of Nursing and Allied Health Literature Centre for Reviews and Dissemination Debategraph Doctor in chiropractic Diplomed in osteopathy (USA: Doctor in osteopathy) Evidence Based Medicine European Council on Chiropractic Education European School of Osteopathy Flanders International College of Osteopathy Fonds voor Wetenschappelijk Onderzoek Facilitated Positional Release Graduate Education Program Groupement National Représentatif des Professionnels de l’Ostéopathie/ Groepering, Nationaal en Representatief van de Professionele Osteopaten Grading of Recommendations Assessment, Development and Evaluation High Velocity Low Amplitude International Academy of Osteopathy Intervalle de confiance/betrouwbaarheidsintervallen International Chiropractors Association Institut William Gardner Sutherland Muscle Energy Techniques Mean Weighted Difference National Institute for Health and Clinical Excellence Nederlands Register voor Osteopathie Non Steroidal Anti-inflammatory Drug Organisation Mondiale de la Santé Wereldgezondheidsorganisatie World Health Organisation Beroepscompetentieprofiel Physiotherapy Evidence Database Proprioceptive Neuromuscular Facilitation
Association Belge des Ostéopathes Classique / Belgische Associatie van Klassieke Osteopaten America Chiropractic Association Anglo-European College of Chiropractic Allied and Complementary Medicine Arrêté Royal Association des Chiropracticiens Belges Belgian School of Osteopathy (Wet) Beroepen in de Individuele Gezondheidszorg Bristish Medical Association Complementary and Alternative Medicine Collège Belge d’Ostéopathie Council of Chiropractic Education Comité Européen de Normalisation European committee for Standardization Cumulative Index of Nursing and Allied Health Literature Centre for Reviews and Dissemination Debategraph Doctor in chiropractic Diplomed in osteopathy (USA: Doctor in osteopathy) Evidence Based Medicine European Council on Chiropractic Education European School of Osteopathy Flanders International College of Osteopathy Fonds National de le Recherche Scientifique Facilitated Positional Release Graduate Education Program Groupement National Représentatif des Professionnels de l’Ostéopathie/ Groepering, Nationaal en Representatief van de Professionele Osteopaten Grading of Recommendations Assessment, Development and Evaluation High Velocity Low Amplitude International Academy of Osteopathy Intervalle de confiance International Chiropractors Association Institut William Gardner Sutherland Moniteur Belge Muscle Energy Techniques Mean Weighted Difference National Institute for Health and Clinical Excellence Nederlands Register voor Osteopathie Non Steroidal Anti-inflammatory Drug Organisation Mondiale de la Santé Profil de compétences professionnel Physiotherapy Evidence Database Proprioceptive Neuromuscular Facilitation Randomised Controlled Trial Roland Morris Disability Questionnaire

At the start of March 2008 an International relations (IR) Unit was created at the FAMHP through the appointment of an IR coordinator. The aim in establishing this unit is to organise the FAMHP’s activities within the context of international relations by coordinating internal and external exchange of information and defending the Belgian position to national and international authorities.
At the start of March 2008 an International relations (IR) Unit was created at the FAMHP through the appointment of an IR coordinator. The aim in establishing this unit is to organise the FAMHP’s activities within the context of international relations by coordinating internal and external exchange of information and defending the Belgian position to national and international authorities.

EPINet TM : Exposure Prevention Information Network (standardized methods for recording and tracking percutaneous injuries and blood and body fluid contacts) FDA: Food and Drug Administration EFPSU: European Federation of Public Service Unions FOD (SPF): Federale OverheidsDienst FBZ: Fonds voor de BeroepZiekten FTC: Emtricitabine GERES: Groupe d ‘Etudes sur le Risque d’Exposition des Soignants (Frankrijk) HAART: Highly active anti retroviral therapy HBV: Hepatitis B virus HBIg: Hepatitis B-immunoglobulin HBe Ag: Hepatitis B-virus core-antigeen HBs Asn: Antistoffen tegen het oppervlakteantigeen van het hepatitis B-virus HCV: Hepatitis C virus HGR: Hoge Gezondheidsraad HGV: Hepatitis G virus HIV: Human immunodeficiency virus HOSPEEM: European Hospital and Healthcare Employers’ Association IDPB: Interne Dienst voor Preventie en Bescherming op het werk IU : International unit (viro titration) NRTI : Nucleoside reverse transcriptase inhibitor NNRTI : Non-nucleoside reverse transcriptase inhibitor OK: Operatiekwartier PBW: Preventie en Bescherming op het Werk PCR: Polymerase chain reaction PI : Protease inhibitor PEP: Post exposure prophylaxis PSO: Prik- en spatongeval (= accidentele contacten met bloed en andere lichaamsvochten) QD: Quaque die (elke dag) RNA: Ribonucleic acid RH: Rusthuis RVT: Rust- en verzorgingstehuizen SIV : Simian immunodeficiency virus (Immunodeficiëntievirus bij apen) TDF : Tenofovir UN xxxx: four-digit numbers that identify hazardous substances assigned by United Nations VAZG: Vlaams Agentschap Zorg en Gezondheid VTE: Voltijds equivalent WIV: Wetenschappelijk Instituut voor Volksgezondheid WZC: Woon- en zorgcentra 3TC: Lamivudine
CDC: Centers for Diseases Control and Prevention (USA) CJD: Creutzfeldt–Jakob disease Cp: Comprimé CSS: Conseil Supérieur de la Santé EACS: European Aids Clinical Society EPI: Equipements de protection individuelle. EPINet TM : Exposure Prevention Information Network (standardized methods for recording and tracking percutaneous injuries and blood and body fluid contacts) FDA: Food and Drug Administration EFPSU: European Federation of Public Service Unions ETP: Equivalent temps-plein FMP: Fonds des Maladies Professionnelles FTC: Emtricitabine GERES: Groupe d ‘Etudes sur le Risque d’Exposition des Soignants (France) HAART: Highly active anti retroviral therapy HOSPEEM: European Hospital and Healthcare Employers’ Association IgHB: Immunoglobulines anti-hépatite B IM: Intra-musculaire IMP: Institut médico-pédagogique INTI: Inhibiteur nucléosidique de la transcriptase inverse INNT: Inhibiteur non nucléosidique de la transcriptase inverse ISP (WIV): Institut Scientifique de Santé Publique LCR: Liquide céphalo-rachidien MR-MRS: Maison de repos – Maison de repos et de soins PCR: Polymerase chain reaction PI: Protease inhibitor (inhibiteur de protéase) PPE: Prophylaxie post-exposition QD: Quaque die (chaque jour) QO: Quartier opératoire SEPPT: Service Externe de Prévention et de Protection au travail SIDA: Syndrome de l'immunodéficience acquise SIPPT: Service Interne de Prévention et de Protection au travail SPF: Service Public Fédéral TDF: Tenofovir UI: Unité internationale UN xxxx : Four-digit numbers that identify hazardous substances assigned by United Nations VIH: Virus de l’immunodéficience humaine VHB: Virus de l’hépatite B VHC: Virus de l’hépatite C VHG: Virus de l’hépatite G VSI: Virus simien de l’immunodéficience 3TC: Lamivudine

Key factor 1 Recognition at national, European and international level ●● Ensuring a strong, recognised identity, internally and externally ●● Implementing the spearheads ●● Ensuring proper coordination at European
Key factor 1 Recognition at national, European and international level ●● Ensuring a strong, recognised identity, internally and externally ●● Implementing the spearheads ●● Ensuring proper coordination at European

This unit is responsible for coordinating the internal and external information flow in a national and international context with a view to harmonising Belgian standpoints.
This unit is responsible for coordinating the internal and external information flow in a national and international context with a view to harmonising Belgian standpoints.

In order to carry out its various tasks optimally, the FAMHP enlists the help of the FAMHP commissions, the national consultation platforms with other government services, institutions and stakeholders and the FAMHP representatives on national and international commissions, committees and working groups.
In order to carry out its various tasks optimally, the FAMHP enlists the help of the FAMHP commissions, the national consultation platforms with other government services, institutions and stakeholders and the FAMHP representatives on national and international commissions, committees and working groups.

Agence Française de Sécurité Sanitaire des Produits de Santé Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten Food and Drug Administration Hoge Gezondheidsraad Institut National du Cancer International Confederation for Plastic Reconstructive & Aesthetic Surgery magnetische-resonantie beeldvorming National Health Service Nederlandse Vereniging voor Plastische Chirurgie Poly Implant Prothèses©/M-Implant© Rijksinstituut voor Ziekte- en Invaliditeitsverzekering Wereld Gezondheidsorganisatie
Agence Fédérale des Médicaments et des Produits de Santé Agence Française de Sécurité Sanitaire des Produits de Santé Conseil Supérieur de la Santé Food and Drug Administration International Confederation for Plastic Reconstructive & Aesthetic Surgery Institut National d’Assurance Maladie-Invalidité Institut National du Cancer Imagerie par Résonance Magnétique National Health Service Nederlandse Vereniging voor Plastische Chirurgie Organisation mondiale de la santé Poly Implant Prothèses©/M-Implant©

To ensure the population the optimal use of the medicines and health products they need, the FAMHP’s team manages, in a recognised, effective and responsible manner, all aspects of this area in consultation with all relevant parties in the health sector and the other national and international authorities.
To ensure the population the optimal use of the medicines and health products they need, the FAMHP’s team manages, in a recognised, effective and responsible manner, all aspects of this area in consultation with all relevant parties in the health sector and the other national and international authorities.

Central to this endeavour are the six key factors which represent the FAMHP’s vision and ambition: ●● Recognition at national, European and international level ●● Developing partnerships with the healthcare
Central to this endeavour are the six key factors which represent the FAMHP’s vision and ambition: ●● Recognition at national, European and international level ●● Developing partnerships with the healthcare

The Federal Agency for Medicines and Health Products faced numerous challenges in 2007: constructing a dynamic and efficient public service thanks to the newly acquired autonomy and transparent and professional management; developing into an institution with a national and international reputation; and becoming a learning organisation, capable of meeting people’s expectations with regard to public health.
The Federal Agency for Medicines and Health Products faced numerous challenges in 2007: constructing a dynamic and efficient public service thanks to the newly acquired autonomy and transparent and professional management; developing into an institution with a national and international reputation; and becoming a learning organisation, capable of meeting people’s expectations with regard to public health.